Budesonide (BUD), sold under the brand name Pulmicort among others, is a steroid medication. It is available as an inhaler, pill, and Injectable Suspension. The inhaled form is used in the long term management of asthma and chronic obstructive pulmonary disease (COPD). The Injectable Suspension is used for allergic rhinitis and nasal polyps. The pills in a delayed release form may be used for inflammatory bowel disease including Crohn’s disease, ulcerative colitis and microscopic colitis. Statistic for budesonide in this report includes three product types: Injectable Suspension, inhaler and Inhalation Powder.
This report contains market size and forecasts of Budesonide in global, including the following market information:
Global Budesonide Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Budesonide Market Sales, 2017-2022, 2023-2028, (M Units)
Global top five Budesonide companies in 2021 (%)
The global Budesonide market was valued at 8440.5 million in 2021 and is projected to reach US$ 10420 million by 2028, at a CAGR of 3.1% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Injectable Suspension Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Budesonide include AstraZeneca, Teva, Mylan, Sandoz, Cosmo Pharmaceuticals, Salix, Chiesi Farmaceutici, Orion Corporation and Cipla, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Budesonide manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Budesonide Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Budesonide Market Segment Percentages, by Type, 2021 (%)
Injectable Suspension
Aerosols
Inhalation Powder
Tablet and Capsule
Global Budesonide Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Budesonide Market Segment Percentages, by Application, 2021 (%)
Respiratory Disease Treatment
Nose Disease Treatment
Inflammatory Bowel Disease Treatment
Others
Global Budesonide Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Units)
Global Budesonide Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Budesonide revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Budesonide revenues share in global market, 2021 (%)
Key companies Budesonide sales in global market, 2017-2022 (Estimated), (M Units)
Key companies Budesonide sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
AstraZeneca
Teva
Mylan
Sandoz
Cosmo Pharmaceuticals
Salix
Chiesi Farmaceutici
Orion Corporation
Cipla
Synmosa Biopharma
Lunan Better Pharma
Shanghai Sine Promod

LEAVE A REPLY

Please enter your comment!
Please enter your name here